欢迎来到天天文库
浏览记录
ID:53019708
大小:213.70 KB
页数:3页
时间:2020-04-12
《《非肌层浸润性膀胱癌行二次电切术的临床疗效分析》.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、中瘤基础与临床2015年6月第28卷第3期·221·非肌层浸润性膀胱癌行二次电切术的临床疗效分析杨彦峰,李亚飞,张道秀,王军,魏金星(郑州大学第一附属医院泌尿外科,河南郑州450052)[摘要]目的观察二次电切治疗非肌层浸润性膀胱癌的疗效,并进一步探讨二次电切的意义及指征。方法28例初次电切诊断为非肌层浸润性膀胱癌(TT)患者于4~6周后行二次电切,进一步明确肿瘤的临床分期。结果二次电切中发现3例(10.7%)存在肿瘤残留情况。9例初次电切分期为T的肿瘤中,二次电切后2例(22.2%)的病理结果为T期,1例(3.6%)病理为T期;而19例
2、初次电切分期为T的肿瘤中,二次电切结果有5例(26.3%)的病理为T期。根据二次电切结果及镜检情况,4例行膀胱部分切除,2例行全膀胱切除+回肠代膀胱术,均得到治愈。结论二次电切可进一步明确非肌层浸润性膀胱癌的临床分期,并指导进一步治疗。[关键词]膀胱肿瘤;非肌层浸润性膀胱癌;二次电切;临床分期DOI:10.3969/j.issn.1673—5412.2015.03.013[中图分类号]R737.14;R730.56[文献标识码]A[文章编号]1673—5412(2015)03—0221—03ClinicalEficiencyofSecon
3、dTransurethralResectionofBladderTumoronNon.muscleInvasiveBladderCancerYangYanfeng,LiYafei,ZhangDaoxiu,WangJun,WeiJinxing(DepartmentofUrologySurgery,theFirstAffiliatedHospital,ZhengzhouUnivemity,Zhengzhou450052,China)[Abstract]ObjectiveToobservetheclinicalefficiencyofsecon
4、dtransurethralresectionofbladdertumoronnon—muscleinvasivebladdercancer,andtoinvestigatethesignificanceandindicationsofsecondtransurethralreset—tionofbladdertumorfornon-muscleinvasivebladdercancer.MethodsThe28patientsfirstdiagnosedwithnon—muscleinvasivebladdercancer(T,T1)a
5、cceptedasecondtransurethralresectionofbladdertumor4-6weekslater.ResultsInthesecondtransurethralresectionofbladdertumor,3patients(10.7%)werefoundtheresidualtumors.Ofthe9patientsfirstdiagnosedwithstageT,2patients(22.2%)wereinstageT1,1patient(3.6%)wereinstageT2;ofthe19patien
6、tsfirstdiagnosedwithstageTl,5patients(26.3%)werediagnosedwithstageT2inthesecondtime.Accordingthesecondpathologyresult,4caseswerecuredthroughpartialresectionoftheblad—der,2caseswerecuredthroughradicalcystectomyandilealneubladder.ConclusionSecondtransurethralresec-tionofbla
7、ddertumorcouldgiveamoreaccuratestageofnon—muscleinvasivebladdercancer,andguidethenexttherapy.[Keywords]bladdertumor;non-muscleinvasivecancer;secondtransurethralresectionofbladdertumor;clini—calstage膀胱癌是最常见的肿瘤之一,发病率位居泌尿系80%E2]。非肌层浸润性膀胱癌首选经尿道膀胱肿瘤肿瘤之首⋯。膀胱癌根据是否浸润肌层分为非肌层电切术进行治
8、疗,并于术后辅助化疗药物(吡柔比星、浸润性(Ti、TT)肿瘤和肌层浸润性(T2以上)肿瘤,丝裂霉素等)或卡介苗进行规律膀胱灌注疗效较其中非肌层浸润性膀胱癌占初诊膀胱癌的70%一好。由于各类膀胱
此文档下载收益归作者所有